Effects of sumatriptan on nitric oxide and superoxide balance during glyceryl trinitrate infusion in the rat. Implications for antimigraine mechanisms

Brain Research

Volumn 847, Issue 1, 1999, Pages 1-8

  Read, Simon J ^a   Manning, Philip ^b   McNeil, Calum J ^b   Hunter, A Jacqueline ^a   Parsons, Andrew A ^a  

^a Neuroscience Research   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Migraine; Nitric oxide; Sumatriptan; Superoxide

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE; PEROXYNITRITE; SUMATRIPTAN; SUPEROXIDE;

ANESTHESIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; MALE; MEAN ARTERIAL PRESSURE; MIGRAINE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICALS; INFUSIONS, INTRAVENOUS; LASER-DOPPLER FLOWMETRY; MALE; MIGRAINE DISORDERS; NITRIC OXIDE; NITROGLYCERIN; RATS; RATS, SPRAGUE-DAWLEY; SUMATRIPTAN; SUPEROXIDES;

EID: 0032702031     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01985-X     Document Type: Article

References (33)

1. Aurora S.K., Welch K.M.A. Brain excitability in migraine: evidence from transcranial magnetic stimulation studies. Curr. Opin. Neurol. 11(3):1998;205-209.
2. Buzzi M.G., Carter W.B., Shimizu T., Heath H. III, Moskowitz M.A. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology. 30(11):1991;1193-1200.
3. Buzzi M.G., Moskowitz M.A. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br. J. Pharmacol. 99:1990;202-206.
4. Chan W.I., Evans J.M., Hadley M.S., Herdon H.J., Jerman J.C., Parsons A.A., Read S.J., Stean T.O., Thompson M., Upton N. Identification of (-)cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamin)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent. Biomed. Chem. Lett. 9:1999;285-290.
5. Ehrentreich-Forster E., Scheller W., McNeil C.J. Biosensor zur in vivo messung von superoxidradikalen. BIOspektrum. 4:1997;34-37.
6. Fabian R.H., DeWitt D.S., Kent T.A. In vivo detection of superoxide anion production by the brain using cytochrome c electrode. J. Cereb. Blood Flow Metab. 15:1995;242-247.
7. Feelisch M. Biotransformation to NO of organic nitrates in comparison to other nitrovasodilators. Eur. Heart J. 14(1):1993;123-132.
8. Ferrari M.D., Haan J., Koos Blokland J.A., Arndt J.W., Minnee P., Zwinderman A.H., Pauwels E.K.J., Saxena P.R. Cerebral blood flow during migraine attacks without aura and effect of sumatripan. Arch. Neurol. 52:1995;135-139.
9. Goadsby P.J., Kaube H., Hoskin K.L. NO couples cerebral blood flow and metabolism. Brain Res. 595:1992;167-170.
10. Iversen H.K., Olesen J. Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of NO. Cephalalgia. 14:1994;437-442.
11. Iversen H.K., Olesen J., Tfelt-Hansen P. Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain. 38:1989;17-24.
12. Janssen I., Olesen J., Edvinsson L. 5-Hydroxytriptamine receptor characterisation of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol. Scand. 147:1993;141-150.
13. Lassen L.H., Ashina M., Christiansen I., Ulrich V., Olesen J. NO synthase inhibition in migraine. Lancet. 349:1997;401-402.
14. Lewis P.J., Barrington S.F., Marsden P.K., Maisey M.N., Lewis L.D. A study of the effect of sumatriptan on myocardial perfusion in healthy female migraineurs using 13NH2 positron emission tomography. Neurology. 48:1997;1542-1550.
15. Longmore J., Boulanger C.M., Desta B., Hill R.G., Schofield W.N., Taylor A.A. 5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519. Br. J. Clin. Pharmacol. 42:1996;431-441.
16. Manning P., McNeil C.J., Hillhouse E.W. Direct, real time sensing of free radical production by activated human glioblastoma cells. Free Radical Biol. Med. 24:1998;1304-1309.
17. Merikangas K.R., Fenton B.T., Cheng S.H., Stolar M.J., Risch N. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch. Neurol. 54:1997;362-368.
18. Olesen J., Iversen H.K., Thomsen L.L. NO supersensitivity: a possible molecular mechanism of migraine pain. NeuroReport. 4:1993;1027-1030.
19. Olesen J., Thomsen L.L., Iversen H. NO is a key molecule in migraine and other vascular headaches. TIPS. 15(5):1994;149-153.
20. Parsons A.A., Raval P., Smith S., Tilford N., King F.D., Kauman A.J., Hunter J. Effects of the novel high-affinity 5HT1B/1D receptor ligand Frovatriptan in human isolated basilar and coronary arteries. J. Cardiovasc. Pharmacol. 32:1998;220-224.
21. 1-like receptors mediate 5-hydroxytriptamine-induced contraction of human isolated basilar artery. Br. J. Pharmacol. 96:1989;434-449.
22. Read S.J., Parsons A.A. NO does not mediate cerebral blood flow changes during cortical spreading depression in the anaesthetised rat. Neurosci. Lett. 250:1998;115-118.
23. S.J. Read, A.A. Parsons, 1999. Cortical spreading depression and migraine. In: Experimental Headache Models in Animal and Man. Ed. Edvinsson. Martin Dunitz Publishers, London.
24. Read S.J., Smith M.I., Hunter A.J., Parsons A.A. Enhanced NO release during cortical spreading depression following infusion of glyceryl trinitrate in the anaesthetised cat. Cephalalgia. 17:1997;159-165.
25. Read S.J., Smith M.I., Hunter A.J., Parsons A.A. The dynamics of NO release measured directly and in real time following repeated waves of cortical spreading depression in the anaesthetised cat. Neurosci. Lett. 232:1997;127-130.
26. Sorkin E.M., Brogden R.N., Romankiewicz J.A. Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy. Drugs. 27:1984;45-80.
27. Spokes R.A., Middlefell V.C. Simultaneous measurement of plasma protein extravasation and carotid vascular resistance in the rat. Eur. J. Pharmacol. 281:1995;75-79.
28. Stamler J.S. Redox signaling: nitrosylation and related target interactions of NO. Cell. 78:1994;931-936.
29. Tammeveski K., Tenno T.T., Mashrin A.A., Hillhouse E.W., Manning P., McNeil C.J. Superoxide electrode based on covalently immobilised cytochrome c: modelling studies. Free Radical Biol. Med. 25(8):1998;973-978.
30. Tassorelli C., Joseph S.A. Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat. Brain Res. 682:1995;167-181.
31. Tolias C.M., McNeil C.J., Kazlauskaite J., Hillhouse E.W. Superoxide generation from constitutive NO synthase in astrocytes in vitro regulates extracellular NO availability. Free Radical Biol. Med. 26:1999;99-106.
32. Wahl M., Schilling L., Parsons A.A., Kaumann Involvement of calcitonin gene-related peptide (CGRP) and NO (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res. 637:1994;204-210.
33. Welch K.M.A. Current opinions in headache pathogenesis: introduction and synthesis. Curr. Opin. Neurol. 11(3):1998;193-197.